| Primary |
| Hypertension |
48.8% |
| Prophylaxis |
13.0% |
| Product Used For Unknown Indication |
6.8% |
| Atrial Fibrillation |
5.1% |
| Cardiac Failure |
4.9% |
| Diabetes Mellitus |
3.6% |
| Essential Hypertension |
3.6% |
| Type 2 Diabetes Mellitus |
3.4% |
| Blood Pressure |
1.4% |
| Cardiac Disorder |
1.1% |
| Depression |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Pain |
1.0% |
| Back Pain |
0.9% |
| Arthritis |
0.8% |
| Myocardial Ischaemia |
0.8% |
| Prostatic Disorder |
0.8% |
| Hepatitis C |
0.7% |
| Hypothyroidism |
0.7% |
| Angina Pectoris |
0.6% |
|
| Renal Failure |
14.7% |
| Renal Failure Acute |
9.3% |
| Vomiting |
6.9% |
| Product Substitution Issue |
6.4% |
| Sepsis |
6.4% |
| Hyponatraemia |
4.9% |
| Renal Impairment |
4.9% |
| Dyspnoea |
4.4% |
| Rhabdomyolysis |
4.4% |
| Death |
3.9% |
| Hypertension |
3.9% |
| Therapeutic Agent Toxicity |
3.9% |
| Drug Interaction |
3.4% |
| Fall |
3.4% |
| Gastrointestinal Haemorrhage |
3.4% |
| Herpes Zoster |
3.4% |
| Vasculitis |
3.4% |
| Hypotension |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Leukocytoclastic Vasculitis |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
24.3% |
| Hypertension |
19.7% |
| Drug Use For Unknown Indication |
16.4% |
| Type 2 Diabetes Mellitus |
5.9% |
| Diabetes Mellitus |
4.9% |
| Muscle Spasms |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Cardiac Disorder |
2.9% |
| Cardiovascular Disorder |
2.7% |
| Essential Hypertension |
2.5% |
| Obesity |
2.2% |
| B-cell Lymphoma |
1.9% |
| Atrial Fibrillation |
1.8% |
| Prophylaxis |
1.4% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Depression |
1.3% |
| Pain |
1.3% |
| Intentional Overdose |
1.2% |
| Urinary Tract Infection |
1.2% |
| Bladder Disorder |
1.1% |
|
| Renal Failure Acute |
22.1% |
| Weight Increased |
18.0% |
| Renal Impairment |
6.2% |
| Weight Decreased |
5.2% |
| Hyperkalaemia |
4.2% |
| Hyponatraemia |
4.2% |
| Renal Failure |
4.2% |
| Vomiting |
4.2% |
| Swollen Tongue |
3.8% |
| Syncope |
3.5% |
| Completed Suicide |
2.8% |
| Respiratory Arrest |
2.8% |
| Rhabdomyolysis |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Emotional Distress |
2.4% |
| Tachycardia |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Bradycardia |
2.1% |
| Nausea |
2.1% |
| Palpitations |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.6% |
| Hypertension |
21.4% |
| Product Used For Unknown Indication |
20.5% |
| Rheumatoid Arthritis |
5.3% |
| Diabetes Mellitus |
4.3% |
| Type 2 Diabetes Mellitus |
3.0% |
| Prophylaxis |
3.0% |
| Depression |
2.5% |
| Pain |
2.5% |
| Atrial Fibrillation |
2.1% |
| Hypercholesterolaemia |
2.0% |
| Osteoporosis |
1.9% |
| Blood Cholesterol Increased |
1.2% |
| Hiv Infection |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypothyroidism |
1.1% |
| Blood Pressure |
1.1% |
| Arthralgia |
1.0% |
| Asthma |
1.0% |
| Diffuse Large B-cell Lymphoma |
1.0% |
|
| Vomiting |
12.4% |
| Weight Decreased |
8.3% |
| Renal Failure Acute |
7.5% |
| Thrombocytopenia |
7.0% |
| Renal Failure |
5.4% |
| Myocardial Infarction |
4.9% |
| Death |
4.7% |
| Pyrexia |
4.6% |
| Somnolence |
4.4% |
| Hypoglycaemia |
4.2% |
| Syncope |
4.2% |
| Pruritus |
4.1% |
| Renal Impairment |
4.1% |
| Weight Increased |
3.7% |
| Rhabdomyolysis |
3.6% |
| International Normalised Ratio Increased |
3.5% |
| Nausea |
3.5% |
| Pain In Extremity |
3.5% |
| Sepsis |
3.4% |
| Dyspnoea |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
16.2% |
| Mental Disorder |
15.2% |
| Hypertension |
14.8% |
| Product Used For Unknown Indication |
7.6% |
| Somatoform Disorder |
7.6% |
| Diabetes Mellitus |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Atrial Fibrillation |
3.8% |
| Blood Cholesterol Increased |
3.8% |
| Herpes Zoster |
3.8% |
| Menopause |
3.8% |
| Hiv Infection |
3.3% |
| Back Pain |
1.9% |
| Bipolar Disorder |
1.9% |
| Pain |
1.9% |
| Dyslipidaemia |
1.0% |
| Glaucoma |
1.0% |
| Gout |
1.0% |
| Hiv Infection Cdc Category B3 |
1.0% |
| Ischaemic Cardiomyopathy |
1.0% |
|
| Renal Failure Acute |
19.5% |
| Drug Interaction |
14.6% |
| Suicidal Ideation |
9.8% |
| Akathisia |
4.9% |
| Hyperkalaemia |
4.9% |
| Rhabdomyolysis |
4.9% |
| Sinus Bradycardia |
4.9% |
| Ventricular Hypokinesia |
4.9% |
| Vomiting |
4.9% |
| Agitation |
2.4% |
| Asthenia |
2.4% |
| Blood Creatinine Increased |
2.4% |
| Bradycardia |
2.4% |
| Coma |
2.4% |
| Dehydration |
2.4% |
| Disorientation |
2.4% |
| Dyspnoea |
2.4% |
| Hypotension |
2.4% |
| Malaise |
2.4% |
| Metabolic Acidosis |
2.4% |
|
